Recombinant Human Delta-like protein 1 (DLL1)

What is the structural composition of human Delta-like protein 1?

Delta-like protein 1 (DLL1) is a 90-100kD type I transmembrane protein belonging to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. The mature human DLL1 consists of three distinct domains: a 528 amino acid extracellular domain (ECD) containing one DSL domain and eight EGF-like repeats, a 23 amino acid transmembrane segment, and a 155 amino acid cytoplasmic domain . This structural arrangement facilitates its interaction with Notch receptors and subsequent signaling activities.

How conserved is DLL1 across species?

Human DLL1 demonstrates high evolutionary conservation, sharing 91% amino acid sequence identity with mouse and rat DLL1 . When compared to other Delta-like family members, human DLL1 shares varying degrees of homology: 26% with DLL2, 37% with DLL3, and 54% amino acid sequence identity with DLL4 . This conservation pattern suggests functional importance across mammalian species and provides a scientific basis for translational research using animal models.

What are the primary biological functions of DLL1?

DLL1 plays critical roles in multiple developmental and physiological processes. It is extensively involved in embryonic somite formation, cochlear hair cell differentiation, and both B and T lymphocyte differentiation . Additionally, DLL1 is crucial in postnatal arteriogenesis, where its upregulation in arterial endothelial cells following injury or angiogenic stimulation facilitates vascular remodeling . In immune regulation, DLL1 belongs to the family of Notch ligands known to selectively drive antigen-specific CD4 T helper 1 cell responses .

How does DLL1 expression oscillate in stem cells and what regulates this oscillation?

Research has revealed that DLL1 exhibits oscillatory expression patterns in muscle progenitor and stem cells . This oscillatory behavior is influenced by multiple regulatory factors, with Hes1 playing a particularly important role. While MyoD is not required for oscillatory DLL1 expression (as demonstrated in MyoD−/− animals carrying a DLL1 allele), it may affect the intensity of expression . Mathematical modeling using delay differential equations has demonstrated that these oscillations depend on precise timing between gene transcription and protein production.

The oscillatory dynamics can be quantified using Fast Fourier transformation (power of FFT), which assesses the stability and periodicity of DLL1 expression cycles . This methodological approach allows researchers to precisely characterize oscillatory patterns under different experimental conditions.

How do mutations in DLL1 affect its oscillatory expression and cellular functions?

Interestingly, experimental data reveals that when only one of two coupled cells possesses a prolonged transcriptional delay, oscillations are only moderately affected . This suggests a compensation mechanism in cellular communities that may have important implications for understanding tissue-level regulation of DLL1 function.

What methodologies are optimal for studying DLL1 oscillatory dynamics in experimental systems?

To effectively study DLL1 oscillatory dynamics, researchers have employed several methodological approaches:

• Luciferase Reporter Systems: DLL1-luciferase fusion proteins allow real-time monitoring of expression dynamics in living cells, requiring exposure times of approximately 6-9 minutes depending on expression levels .

• Fast Fourier Transformation Analysis: This mathematical technique can quantitatively assess the stability and periodicity of oscillations from time-series data .

• Cultured Tissue Slices: For developmental studies, cultured slices from embryonic limbs (e.g., E11.5 mice) provide insights into DLL1 dynamics during tissue development .

• Floating Fiber Cultures: This technique allows assessment of DLL1 dynamics specifically in muscle stem cells while maintaining their native niche interactions .

How is DLL1 implicated in visceral leishmaniasis susceptibility?

Genetic studies have identified Chromosome 6q26–27, where DLL1 is located, as linked to susceptibility to visceral leishmaniasis (VL) in multiple geographical regions including Brazil, Sudan, and India . Population-based studies have revealed specific single nucleotide polymorphisms (SNPs) at DLL1 and the nearby FAM120B gene that associate with VL susceptibility. The most significant protective haplotype (frequency 0.18; P=0.007) was identified as a 5-SNP haplotype across the interval 5' of both DLL1 and FAM120B .

Functional evidence supporting DLL1's role in VL comes from expression studies in pre- and post-treatment splenic aspirates from VL patients. DLL1 was the only gene in the region to show differential expression between these conditions, with significantly higher expression (P<0.0001) in pre-treatment samples . This suggests that regulation of DLL1 gene expression is important in disease pathogenesis.

What is the role of DLL1 in immune regulation during infection?

DLL1 belongs to the family of Notch ligands that selectively drive antigen-specific CD4 T helper 1 (Th1) cell responses, which are crucial for protective immunity against intracellular pathogens, including Leishmania species . The potential for Delta-1 driven Th1 differentiation to alter infection outcomes has been demonstrated experimentally for L. major infection in BALB/c mice .

In visceral leishmaniasis, DLL1's role in Th1 differentiation appears paradoxical, as DLL1 expression decreases post-treatment. This may reflect the complex immunopathology of VL, where high levels of pro-inflammatory cytokines like TNF-α contribute to fever and cachexia during active disease . The precise balance of DLL1-mediated signaling may therefore be critical in determining disease progression versus resolution.

How is DLL1 involved in oncogenesis?

DLL1 has been found to be overexpressed in several cancer types, including cervical carcinoma and glioma, where it contributes to tumor progression . The mechanisms may involve dysregulation of Notch signaling pathways that control cell fate decisions, proliferation, and survival. Research into DLL1's role in cancer has potential implications for developing targeted therapies that modulate Notch signaling in malignant cells.

What experimental systems are most suitable for studying DLL1 function in stem cell biology?

Several experimental systems have proven valuable for investigating DLL1 function in stem cell biology:

• Cultured Floating Fibers: This system enables the study of muscle stem cell colonies while maintaining their native niche. In this model, colonies on fibers from DLL1type2 mutant mice showed reduced colony size after 72h in culture, with increased MyoG+ cells and decreased Pax7+ cells, indicating enhanced differentiation at the expense of self-renewal .

• Sphere Cultures: When cultured in spheres, DLL1type2 mutant muscle stem cells show a higher propensity to differentiate compared to wild-type cells, as assessed by MyoG+ and Pax7+ cell percentages .

• Chimeric Spheres: When DLL1type2 mutant cells are surrounded by wild-type cells in chimeric spheres, differentiation is suppressed, demonstrating the importance of cell-cell interactions in regulating DLL1 function .

• In vivo Muscle Regeneration Models: These models allow assessment of DLL1 function during tissue repair processes under physiological conditions .

What techniques are effective for analyzing DLL1 genetic variants and their functional impacts?

This table summarizes key techniques used in the genetic analysis of DLL1. For instance, logistic regression analysis under an additive model has been used to identify associations between visceral leishmaniasis and variants at DLL1 and FAM120B, with top associations at rs9460106 (OR=1.17, 95%CI 1.01–1.35, P=0.033) and rs2103816 (OR=1.16, 95%CI 1.01–1.34, P=0.039) .

How can researchers effectively model DLL1-Notch signaling interactions between cells?

Mathematical modeling has proven valuable for understanding the complex dynamics of DLL1-Notch signaling. Researchers have employed delay differential equation models to simulate expression dynamics in both single cells and coupled cell systems . These models incorporate parameters such as:

• Transcriptional Delay (τ): The time required for Hes1 to affect DLL1 protein levels, estimated to be approximately 0.35 hours in wild-type cells .

• Synthesis Rates: The production rates of both mRNA and protein.

• Half-lives: The degradation rates of both mRNA and protein.

The model predicts that in two coupled cells, DLL1 will oscillate in both cells with oscillations occurring with a shift of half a phase period . This modeling approach enables researchers to predict how genetic or pharmacological perturbations might affect signaling dynamics before conducting resource-intensive experimental validation.

How might single-cell technologies advance our understanding of DLL1 expression heterogeneity?

Single-cell RNA sequencing and other single-cell technologies offer promising approaches to better understand the heterogeneity of DLL1 expression within tissues. These technologies could reveal how individual cells within a population differ in their expression dynamics and how these differences contribute to cell fate decisions. Future research should focus on correlating single-cell DLL1 expression patterns with functional outcomes in various biological contexts.

What are the implications of DLL1 oscillatory dynamics for regenerative medicine?

The oscillatory expression of DLL1 has significant implications for stem cell-based regenerative medicine. Understanding how these oscillations regulate the balance between self-renewal and differentiation could inform strategies to optimize stem cell expansion and directed differentiation for therapeutic applications. Researchers should investigate whether manipulating DLL1 expression dynamics could enhance tissue regeneration in various pathological contexts.

How do environmental factors influence DLL1 expression and function?

An emerging area for investigation is how environmental factors, including inflammatory stimuli, metabolic changes, and physical forces, affect DLL1 expression and signaling. Research has shown that DLL1 is upregulated in arterial endothelial cells following injury or angiogenic stimulation , suggesting responsiveness to environmental cues. Understanding these regulatory mechanisms could provide insights into how DLL1 function is modulated in different physiological and pathological contexts.